The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Lemeshevskaia O.I.

Saint-Petersburg State University

Kamaeva E.A.

Saint-Petersburg State University

Lukashenko M.V.

Saint-Petersburg State University

Gavrilova N.Yu.

Saint-Petersburg State University

Soprun L.A.

Saint-Petersburg State University

The successful use of Cytoflavin in the patient with postaveny syndrome

Authors:

Lemeshevskaia O.I., Kamaeva E.A., Lukashenko M.V., Gavrilova N.Yu., Soprun L.A.

More about the authors

Read: 1993 times


To cite this article:

Lemeshevskaia OI, Kamaeva EA, Lukashenko MV, Gavrilova NYu, Soprun LA. The successful use of Cytoflavin in the patient with postaveny syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(7):108‑111. (In Russ.)
https://doi.org/10.17116/jnevro2023123071108

Recommended articles:
Neuprotection of post-acute COVID-19 cognitive impairment. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):106-111
Post-COVID syndrome in children: features of pathophysiology, diagnosis and therapy. Russian Journal of Preventive Medi­cine. 2024;(7):94-100
Pathogenesis of pulmonary fibrosis. Russian Journal of Archive of Pathology. 2024;(4):58-63
Cochleovestibular mani­festations in coro­navirus infe­ction. Russian Bulletin of Otorhinolaryngology. 2024;(3):18-23
Pediatric sensorineural hearing loss rela­ted COVID-19. Clinical cases. Russian Bulletin of Otorhinolaryngology. 2024;(3):64-68

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.